Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.

作者: Gordana Petrovic , Goran Bjelakovic , Daniela Benedeto-Stojanov , Aleksandar Nagorni , Vesna Brzacki

DOI: 10.2298/VSP150514093P

关键词: Fatty liverHepatologyObesityBody mass indexInternal medicineDiabetes mellitusDyslipidemiaMetabolic syndromeGastroenterologyChronic liver diseaseEndocrinologyMedicine

摘要: Introduction/ aim. Non-alcoholic fatty liver disease (NAFLD) is a chronic of broad histological spectrum, characterized by the accumulation triglycerides in more than 5% hepatocytes the absence consuming alcohol quantities harmful to liver. The aim our study was determine importance anthropometric and laboratory parameters as well metabolic syndrome (MS) for diagnosis NAFLD estimate their influence on degree steatosis evaluated ultrasound (US). Methods. study included 86 participants, 55 whom had liver diagnosed ultrasound they comprised group. control group consisted 31 subjects. During course hospitalization at Clinic Gastroenterology Hepatology, Clinical Centre Nis, patients anamnesis taken, measurements as biochemical blood analyses abdominal were performed. Results. patients with statistically higher values body mass index (BMI), waist circumference (WC), systolic (SBP) diastolic pressure (DBP), levels alanin aspartate aminotransferase (ALT, AST), gamma-glutamyl transpeptidase (GGT) (p<0.001), low-density lipoprotein cholesterole (LDL), total bilirubin (TBIL) (p<0.05), cholesterol (p<0.01), (TGL), urates, C-reactive protein (CRP), ferritin, fibrinogenes, fasting glucose (FBG), insulin Homeostasis Model Assessment (HOMA-IR) whereas high-density lipoprotein cholesterol (HDL) group (p<0.05). In group, there significantly with hypertension (72.73% vs. 12.90%, p<0.001) type 2 diabetes mellitus (DM) (47.27%). Metabolic determined 48 (87.27%) An equal number patients, 16 them (29.09%), 3, 4 5 components MS. In 17 overweight (30.91%) (BMI from 25 kg/m2 29.9 kg/m2) 38 (69.09%) obese patients. (BMI ≥ 30.0 kg/m2). largest obesity 22 (40.00%) of them, first 30 34.99 The - 23 (41.82%), an finding grade 3 liver, 20 (36.36%) 12 (21.82%) 1 Kruskal-Wallis test ANOVA analysis showed significant differences between groups different US grade insulin, LDL-cholesterol, WC, BMI HOMA-IR body weight (BW) (p<0.01). present in grades (p<0.01) relation US finding, obesity, DM Conclusion. results have confirmed that high percentage risk factors (DM, MS, dyslipidemia, hypertension) NAFLD.

参考文章(52)
Radu Badea, Monica Lupsor, Imaging diagnosis and quantification of hepatic steatosis: is it an accepted alternative to needle biopsy? Romanian journal of gastroenterology. ,vol. 14, pp. 419- 425 ,(2005)
Bandgar T, Menon Ps, Joshi As, Shah Ns, Rathi Pm, Vima Mv, Joshi, Prashanth M, Shah, John M, Thakkar H, Ganesh Hk, Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Journal of Association of Physicians of India. ,vol. 57, pp. 205- 210 ,(2009)
Ping Yein Lee, Whye Lian Cheah, Ching Thon Chang, Siong Long Wong, Hamid Jan Mohamed, PREVALENCE OF ULTRASOUND DIAGNOSED NON- ALCOHOLIC FATTY LIVER DISEASE AMONG RURAL INDIGENOUS COMMUNITY OF SARAWAK AND ITS ASSOCIATION WITH BIOCHEMICAL AND ANTHROPOMETRIC MEASURES Southeast Asian Journal of Tropical Medicine and Public Health. ,vol. 44, pp. 309- ,(2013)
Sina Abdollahzade, Nasser Ebrahimi Daryani, Mohammad Reza Keramati, Seyed Moayed Alavian, Ali Zare, Seyed-Mohammad Fereshtehnejad, Narges Ebrahimi Daryani, Sahar Taba taba Vakili, Somaye Khosravi, Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings Hepatitis Monthly. ,vol. 11, pp. 452- 458 ,(2011)
K Paletas, P Paschos, Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia. ,vol. 13, pp. 9- 19 ,(2009)
Guilherme F. M. Rezende, Claudia R. L. Cardoso, Gil F. Salles, Nathalie C. Leite, Cristiane A. Villela-Nogueira, Vera L. N. Pannain, Adriana C. Bottino, Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors. Liver International. ,vol. 31, pp. 700- 706 ,(2011) , 10.1111/J.1478-3231.2011.02482.X
Arun J. Sanyal, NASH: A global health problem Hepatology Research. ,vol. 41, pp. 670- 674 ,(2011) , 10.1111/J.1872-034X.2011.00824.X
Naga Chalasani, Zobair Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal, The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association Hepatology. ,vol. 55, pp. 2005- 2023 ,(2012) , 10.1002/HEP.25762
Pouneh Mofrad, Melissa J Contos, Mahmadul Haque, Carol Sargeant, Robert A Fisher, Velimir A Luketic, Richard K Sterling, Mitchell L Shiffman, Richard T Stravitz, Arun J Sanyal, Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values Hepatology. ,vol. 37, pp. 1286- 1292 ,(2003) , 10.1053/JHEP.2003.50229
Mariana Machado, Pedro Marques-Vidal, Helena Cortez-Pinto, Hepatic histology in obese patients undergoing bariatric surgery Journal of Hepatology. ,vol. 45, pp. 600- 606 ,(2006) , 10.1016/J.JHEP.2006.06.013